Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372631 · ClinicalTrials.gov registry record · NA
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 218
- Enrollment target
NCT01372631 is a NA study that has completed, run by Duke University. The registered enrollment target is 218 participants.
The verdict
NCT01372631, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
Study Summary
The goal of this research is to further develop novel optical assay systems for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens.
Interventions
- DEVICE miniature spectral imaging system
- DEVICE Bench-top optical spectrometer
- DEVICE High resolution microendoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2011-04 |
| Est. Completion | 2017-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01372631
The ClinicalTrials.gov registry entry for NCT01372631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which miniature spectral imaging system is the first listed.
NCT01372631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01372631 about?
NCT01372631 is a clinical study titled "A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins". The goal of this research is to further develop novel optical assay systems for intra operative assessment of tumor margins in partial mastectomy or mastectomy specimens.
What is the current status of trial NCT01372631?
This trial is currently completed. It is a NA study. The enrollment target is 218 participants. The study started on 2011-04. Estimated completion is 2017-04-01.
What interventions are being tested in trial NCT01372631?
The interventions under investigation include: miniature spectral imaging system (DEVICE), Bench-top optical spectrometer (DEVICE), High resolution microendoscope (DEVICE).
Who is sponsoring clinical trial NCT01372631?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.